Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Aug 26, 2014; 6(8): 865-873
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.865
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.865
Risk stratification for ST segment elevation myocardial infarction in the era of primary percutaneous coronary intervention
Richard A Brogan, Christopher P Gale, Leeds Institute of Cardiovascular and Metabolic Medicine, Division of Epidemiology and Biostatistics, University of Leeds, Leeds LS2 9JT, United Kingdom
Richard A Brogan, York and Hull Medical School, University of York, York, YO10 5DD, United Kingdom
Christopher J Malkin, Alexander D Simms, James M McLenachan, Department of Cardiology, Leeds Teaching Hospital NHS Trust, Leeds LS2 9JT, United Kingdom
Phillip D Batin, Department of Cardiology, Pinderfields General Hospital, Mid Yorkshire NHS Trust, Wakefield WF5 9LZ, United Kingdom
Christopher P Gale, Department of Cardiology, York Teaching Hospital NHS Foundation Trust, York YO10 5DD, United Kingdom
Author contributions: Brogan RA, Malkin CJ and Gale CP concepted, designed, interpreted, drafted and final approved the article; Batin PD, Simms AD and McLenachan JM interpreted, drafted and final approved the article.
Correspondence to: Richard A Brogan, MB ChB, BSc, MRCP, Leeds Institute of Cardiovascular and Metabolic Medicine, Division of Epidemiology and Biostatistics, University of Leeds, Level 8, Worsely Building, Clarendon Way, Leeds, West Yorkshire, LS2 9JT, United Kingdom. richard.brogan@nhs.net
Telephone: +44-01-133438924 Fax: +44-01-133434877
Received: December 28, 2013
Revised: April 30, 2014
Accepted: May 29, 2014
Published online: August 26, 2014
Revised: April 30, 2014
Accepted: May 29, 2014
Published online: August 26, 2014
Core Tip
Core tip: Risk stratification is recommended in non ST segment elevation myocardial infarction (NSTEMI) by multiple international cardiology agencies however there is no such recommendation for STEMI. The short term risk of STEMI is perceived to be high and warrant emergency percutaneous coronary intervention rather than pharmacological fibrinolysis. The risk spectrum is wide therefore consideration should be given to developing an optimal reperfusion strategy based on risk of adverse outcome and probability of reperfusion regardless of mode of reperfusion.